Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck

A legfontosabb adatok

Ki végzi
Johns Hopkins University
Hol
Baltimore és Washington D.C. (Egyesült Államok)Mind a 2 helyszín megnézése
Azonosító
Állapot
Leállítva
Résztvevők
1 fő vett részt
Kezdés
2024. febr. 1.
Befejezés
2025. máj. 14.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A vizsgált kezelések
  • Ultrasound
A regiszteradat frissítve
2026. március 9.
Miért állt le
Expired in IRB

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 6 feltétel megnézéseKevesebb

Ki vehet részt

  • All cSCC must be on the head or neck
  • All cSCC must be primary tumors
  • BWH stage T2a tumors in patients who are on chronic immunosuppression (organ transplant, hematologic malignancy, autoimmune disease)
  • All BWH T2b or T3 tumors with a negative CT of the nodal basin AND a negative SLNB

Ki nem vehet részt

  • Recurrent tumors
  • Patients who are BWH T2b/T3 who have a positive CT of the nodal basin or positive lymph node biopsy

Helyszínek itt: Egyesült Államok

  • Johns Hopkins HospitalBaltimore, Egyesült Államok
  • Sibley Memorial HospitalWashington D.C., Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

In this prospective cohort study, investigators will conduct ultrasound surveillance of the nodal basins of patients with head and neck cutaneous squamous cell carcinoma (cSCC) whose tumors are considered high risk and staged by the Brigham and Women's Hospital (BWH) tumor staging system. The study will enroll patients with tumors staged T2a and who are also immunosuppressed (from solid organ transplant, hematologic malignancy or autoimmune disease), T2b (sentinel lymph node negative), and T3 (sentinel lymph node negative). After two years of surveillance, outcomes regarding local recurrence, nodal metastasis, disease specific death, and overall survival will be compared with historical controls with the overall hypothesis that ultrasound surveillance will detect subclinical disease earlier and help improve outcomes.

A vizsgálat 3 csoportja

  • BWH stage T2a tumors in patients who are on chronic immunosuppression

    Patient's whose cutaneous squamous cell carcinoma is BWH stage T2a and also have a history of organ transplant, hematologic malignancy, autoimmune disease. After these participants are diagnosed, the participants are entered into the study without any further imaging or sentinel lymph node biopsy. The participants will have ultrasound surveillance every 6 months and regular visits every 3 months throughout the duration of the study (2 years).

    Kezelés: Ultrasound

  • BWH stage T2b

    Participants whose cutaneous squamous cell carcinoma is BWH stage T2b. Participants will initially undergo CT imaging of the nodal basin immediately after diagnosis. If the CT is positive, the participants will be excluded from the study. If the CT is unremarkable, patients will undergo sentinel lymph node biopsy (SLNB), which has a higher sensitivity to detect occult micro-metastases. If the SLNB is negative, the participants are entered into the study. The participants will have ultrasound surveillance every 6 months and regular visits every 3 months throughout the duration of the study (2 years).

    Kezelés: Ultrasound

  • BWH stage T3

    Participants whose cutaneous squamous cell carcinoma is BWH stage T3. Participants will initially undergo CT imaging of the nodal basin immediately after diagnosis. If the CT is positive, The participants will be excluded from the study. If the CT is unremarkable, patients will undergo sentinel lymph node biopsy (SLNB), which has a higher sensitivity to detect occult micro-metastases. If the SLNB is negative, the participants are entered into the study The participants will have ultrasound surveillance every 6 months and regular visits every 3 months throughout the duration of the study (2 years).

    Kezelés: Ultrasound

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. március 9.